Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry
Stroke · 2024-08 · 55 (8) · 2103-2112
DOI: 10.1161/strokeaha.124.046690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2024-08. Verfasst von Aristeidis H Katsanos und 35 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada (A.H.K., L.C., A.S., M.S.). Hauptthemen laut MEDLINE: Registries, Endovascular Procedures, Patient Transfer, Thrombectomy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Interhospital transfer for patients with stroke due to large vessel occlusion for endovascular thrombectomy (EVT) has been associated with treatment delays. METHODS: We analyzed data from Optimizing Patient Treatment in Major Ischemic Stroke With EVT, a quality improvement registry to support EVT implementation in Canada. We assessed for unadjusted differences in baseline characteristics, time metrics, and procedural outcomes between patients with large vessel occlusion transferred for EVT and those directly admitted to an EVT-capable center. RESULTS: Between January 1, 2018, and December 31, 2021, a total of 6803 patients received EVT at 20 participating centers (median age, 73 years; 50% women; and 50% treated with intravenous thrombolysis). Patients transferred for EVT (n=3376) had lower rates of M2 occlusion (22% versus 27%) and higher rates of basilar occlusion (9% versus 5%) compared with those patients presenting directly at an EVT-capable center (n=3373). Door-to-needle times were shorter in patients receiving intravenous thrombolysis before transfer compared with those presenting directly to an EVT center (32 versus 36 minutes). Patients transferred for EVT had shorter door-to-arterial access times (37 versus 87 minutes) but longer last seen normal-to-arterial access times (322 versus 181 minutes) compared with those presenting directly to an EVT-capable center. No differences in arterial access-to-reperfusion times, successful reperfusion rates (85% versus 86%), or adverse periprocedural events were found between the 2 groups. Patients transferred to EVT centers had a similar likelihood for good functional outcome (modified Rankin Scale score, 0–2; 41% versus 43%; risk ratio, 0.95 [95% CI, 0.88–1.01]; adjusted risk ratio, 0.98 [95% CI, 0.91–1.05]) and a higher risk for all-cause mortality at 90 days (29% versus 25%; risk ratio, 1.15 [95% CI, 1.05–1.27]; adjusted risk ratio, 1.14 [95% CI, 1.03–1.28]) compared with patients presenting directly to an EVT center. CONCLUSIONS: Patients transferred for EVT experience significant delays from the time they were last seen normal to the initiation of EVT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada (A.H.K., L.C., A.S., M.S.).
- Department of Neurosciences, Université de Montréal and Centre Hospitalier de l'Université de Montréal, QC, Canada (A. Poppe).
- Division of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada (R.H.S., A.Y.X.Y.).
- Department of Clinical Neurological Sciences, London Health Sciences Centre and Western University, ON, Canada (J.M.).
- Department of Radiology, University of Manitoba, Winnipeg, Canada (J.S.).
- Division of Neurology (S.Y.), The University of British Columbia, Vancouver, Canada.
ORCID-Profile: Aristeidis H Katsanos, Alexandre Poppe, Rick H Swartz, Jennifer Mandzia, Luciana Catanese, Jai Shankar, Steve Verreault, George Medvedev, Aditya Bharatha, David Volders, Michael Kelly, Federico Carpani, Aleksandra Pikula, Alexander Tkach, Ramana Appireddy, Aviraj Deshmukh, Mohammed Almekhlafi, Robert Fahed, Noreen Kamal, Bijoy Menon, Ashkan Shoamanesh, Amy Y X Yu, Mukul Sharma, Andrew M Demchuk, Grant Stotts
Zitieren
APA
Katsanos, A. H., Poppe, A., Swartz, R. H., Mandzia, J., Catanese, L., Shankar, J., Yip, S., Verreault, S., Medvedev, G., Maran, I., Legault, C., Ferguson, D., Archer, B., Bharatha, A., Volders, D., Kelly, M., Carpani, F., Pikula, A., Tkach, A., …, & Stotts, G. (2024). Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry. Stroke, 55(8), 2103-2112. https://doi.org/10.1161/strokeaha.124.046690
Vancouver
Katsanos AH, Poppe A, Swartz RH, Mandzia J, Catanese L, Shankar J, et al. Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry. Stroke. 2024;55(8):2103-2112. doi:10.1161/strokeaha.124.046690
BibTeX
@article{Katsanos2024,
author = {Katsanos, Aristeidis H and Poppe, Alexandre and Swartz, Rick H and Mandzia, Jennifer and Catanese, Luciana and Shankar, Jai and Yip, Samuel and Verreault, Steve and Medvedev, George and Maran, Ilavarasy and Legault, Catherine and Ferguson, Darren and Archer, Brian and Bharatha, Aditya and Volders, David and Kelly, Michael and Carpani, Federico and Pikula, Aleksandra and Tkach, Alexander and Moreau, Francois and Beaudry, Michel and Appireddy, Ramana and Deshmukh, Aviraj and Almekhlafi, Mohammed and Fahed, Robert and Kamal, Noreen and Menon, Bijoy and Shoamanesh, Ashkan and Williams, Heather and Yu, Amy Y X and Heran, Manraj K S and Hill, Michael D and Sharma, Mukul and Earl, Karen and Demchuk, Andrew M and Stotts, Grant},
title = {Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry},
journal = {Stroke},
year = {2024},
volume = {55},
number = {8},
pages = {2103--2112},
doi = {10.1161/strokeaha.124.046690}
}
EUVIMED